TEVA Teva Pharmaceutical Industries...
- 19.95 P/E
- 1.69 P/S
- 1.5 P/B
- 2.003 EPS
- 10.43% Cash ROIC
- 0.08 Cash Ratio
- 1.136 / 2.84% Dividend
- 4.08M Avg. Vol.
- 852.00M Shares
- 34.276B Market Cap.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs in various therapeutic categories worldwide. It offers generic pharmaceutical products in a range of dosage forms, such as tablets, capsules, ointments, creams, liquids, injectables, and inhalants. The company also provides branded products, including Copaxone to treat multiple sclerosis...
Mesh Press (press release) - Apr 22, 2013
Insider Monkey (blog) - May 15, 2013
Insider Monkey (blog) - May 8, 2013
4-traders (press release) - May 2, 2013
ValueWalk - May 10, 2013
Galaxy Stocks - May 13, 2013
24/7 Wall St. - May 9, 2013
SBWire (press release) - May 10, 2013
The Utah People's Post - May 8, 2013
Reuters Key Development - May 2, 2013